CDP 571 humanized anti-TNF antibody: CTP's two Phase IIb studies

Celltech Group plc (LSE:CTP), Slough, U.K. Product: CDP 571 humanized anti-TNF antibody Indication: Treat Crohn's disease Status: CTP's two Phase IIb studies in a total of 230 patients with either act...